Pancreatic Cancer Research

ResearcherIndiana University IndianapolisActive in the last 2 years

Silpa Gampala

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9928-3941; OpenAlex author ID A5006252571. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 4 papers

Papers 8

  1. Depletion of Fibrinogen Suppresses Growth of Primary Tumors and Metastasis of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1053/j.gastro.2025.09.024↗
  2. Beyond Cys65: Redox Effector Factor-1 CRISPR-Engineered Cys93 and Cys99 Mutants Reveal Cooperative and Secondary Roles of Redox Signaling and Pancreatic Ductal… Co-author DOI 10.1177/15230864261489484↗
  3. Targeting APE1 endonuclease activity impairs metastasis and enhances genotoxic therapy response in pancreatic cancer. Co-author DOI 10.1186/s13046-026-03705-7↗
  4. Integrated Post-Translational Modification (PTM) Proteomics Reveals Early Redox and Mitochondrial Remodeling Following Ref-1 Inhibition in Pancreatic Cancer Co-author DOI 10.2139/ssrn.7345898↗
  5. In vitro and In vivo evidence demonstrating chronic absence of Ref-1 Cysteine 65 impacts Ref-1 folding configuration, redox signaling, proliferation and metast… Co-author DOI 10.1016/j.redox.2023.102977↗
  6. Activation of the integrated stress response (ISR) pathways in response to Ref-1 inhibition in human pancreatic cancer and its tumor microenvironment. Co-author DOI 10.3389/fmed.2023.1146115↗
  7. RelA Is an Essential Target for Enhancing Cellular Responses to the DNA Repair/Ref-1 Redox Signaling Protein and Restoring Perturbated Cellular Redox Homeostas… Co-author DOI 10.3389/fonc.2022.826617↗
  8. Ref-1 redox activity alters cancer cell metabolism in pancreatic cancer: exploiting this novel finding as a potential target. Co-author DOI 10.1186/s13046-021-02046-x↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Melissa L. Fishel · 8 shared papers, 2021–2026 · strength 1.66
  2. Mark R. Kelley · 7 shared papers, 2021–2026 · strength 1.44
  3. Mahmut Mijit · 5 shared papers, 2022–2026 · strength 1.04
  4. Eyram K. Kpenu · 4 shared papers, 2023–2026 · strength 0.89
  5. Sanya Haiaty · 2 shared papers, 2026 · strength 0.51
  6. Rajesh Sardar · 2 shared papers, 2026 · strength 0.51
  7. Nayela N. Chowdhury · 2 shared papers, 2024–2026 · strength 0.42
  8. Alisa S. Wolberg · 1 shared paper, 2026 · strength 0.22
  9. Wei Ping Jia · 1 shared paper, 2026 · strength 0.22
  10. Sae Rome Choi · 1 shared paper, 2026 · strength 0.22
  11. Matthew J. Flick · 1 shared paper, 2026 · strength 0.22
  12. Christian Schneeweis · 1 shared paper, 2022 · strength 0.15
  13. Zonera Hassan · 1 shared paper, 2022 · strength 0.15
  14. Fenil Shah · 1 shared paper, 2021 · strength 0.11
  15. Hye‐ran Moon · 1 shared paper, 2021 · strength 0.11
  16. Bumsoo Han · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.